Seattle Pituitary Center, Swedish Neuroscience Institute, Seattle, Washington; and.
J Neurosurg. 2013 Dec;119(6):1453-60. doi: 10.3171/2013.8.JNS13411. Epub 2013 Sep 20.
Transient delayed postoperative hyponatremia (DPH) after transsphenoidal surgery (TSS) is common and can have potentially devastating consequences. However, the true prevalence of transient symptomatic and asymptomatic DPH has not been studied in a large patient cohort with close and accurate follow-up.
A retrospective analysis of a single-institution prospective database was conducted; all patients undergoing TSS for lesions involving the pituitary gland were followed up in a multidisciplinary neuroendocrine clinic, and demographic, imaging, and clinical data were prospectively collected. Patients were examined preoperatively and followed up postoperatively in a standardized fashion, and their postoperative sodium levels were measured at Weeks 1 and 2 postoperatively. Levels of hyponatremia were rated as mild (serum sodium concentration 130-134 mEq/L), moderate (125-129 mEq/L), or severe (< 125 mEq/L). Routine clinical questionnaires were administered at all postoperative office visits. Postoperative hyponatremia was analyzed for correlations with demographic and clinical features and with immediate postoperative physiological characteristics.
Over a 4-year interval, 373 procedures were performed in 339 patients who underwent TSS for sellar and parasellar lesions involving the pituitary gland. The mean (± SD) age of patients was 48 ± 18 years; 61.3% of the patients were female and 46.1% were obese (defined as a body mass index [BMI] ≥ 30). The overall prevalence of DPH within the first 30 days postoperatively was 15.0%; 7.2% of the patients had mild, 3.8% moderate, and 3.8% severe hyponatremia. The incidence of symptomatic hyponatremia requiring hospitalization was 6.4%. The Fisher exact test detected a statistically significant association of DPH with female sex (p = 0.027) and a low BMI (p = 0.001). Spearman rank correlation detected a statistically significant association between BMI and nadir serum sodium concentration (r = 0.158, p = 0.002) and an inverse association for age (r = -0.113, p = 0.031). Multivariate analyses revealed a positive correlation between postoperative hyponatremia and a low BMI and a trend toward association with age; there were no associations between other preoperative demographic or perioperative risk factors, including immediate postoperative alterations in serum sodium concentration. Patients were treated with standardized protocols for hyponatremia, and DPH was not associated with permanent morbidity or mortality.
Delayed postoperative hyponatremia was a common result of TSS; a low BMI was the only clear predictor of which patients will develop DPH. Alterations in immediate postoperative sodium levels did not predict DPH. Therefore, an appropriate index of suspicion and close postoperative monitoring of serum sodium concentration should be maintained for these patients, and an appropriate treatment should be undertaken when hyponatremia is identified.
经蝶窦手术(TSS)后短暂性延迟术后低钠血症(DPH)很常见,可能产生潜在的灾难性后果。然而,在接受密切和准确随访的大型患者队列中,尚未对有症状和无症状的短暂性 DPH 的真实患病率进行研究。
对单机构前瞻性数据库进行回顾性分析;所有接受 TSS 治疗涉及垂体病变的患者均在多学科神经内分泌诊所接受随访,并前瞻性收集人口统计学、影像学和临床数据。患者在术前和术后以标准化的方式进行检查,并在术后第 1 和第 2 周测量术后钠水平。低钠血症的严重程度评为轻度(血清钠浓度 130-134 mEq/L)、中度(125-129 mEq/L)或重度(<125 mEq/L)。在所有术后就诊时都进行了常规临床问卷。分析了术后低钠血症与人口统计学和临床特征以及与术后即刻生理特征的相关性。
在 4 年的时间间隔内,339 名患者接受了 373 例 TSS 治疗涉及垂体的鞍区和鞍旁病变。患者的平均(± SD)年龄为 48 ± 18 岁;61.3%的患者为女性,46.1%为肥胖(定义为 BMI[体重指数]≥30)。术后 30 天内 DPH 的总体患病率为 15.0%;7.2%的患者有轻度、3.8%的患者有中度、3.8%的患者有重度低钠血症。需要住院治疗的有症状低钠血症的发生率为 6.4%。Fisher 确切检验检测到 DPH 与女性(p=0.027)和低 BMI(p=0.001)之间存在统计学显著关联。Spearman 秩相关检测到 BMI 与血清钠浓度最低值之间存在统计学显著相关性(r=0.158,p=0.002),与年龄呈负相关(r=-0.113,p=0.031)。多变量分析显示,术后低钠血症与 BMI 较低呈正相关,且与年龄呈关联趋势;其他术前人口统计学或围手术期危险因素之间无关联,包括术后即刻血清钠浓度的改变。患者接受了低钠血症的标准化治疗方案,DPH 与永久性发病率或死亡率无关。
TSS 后延迟性术后低钠血症是常见的结果;BMI 较低是唯一明确预测患者会发生 DPH 的因素。术后即刻钠水平的改变并不能预测 DPH。因此,应对这些患者保持适当的警惕性,并密切监测术后血清钠浓度,一旦发现低钠血症应进行适当的治疗。